share_log

ASP Isotopes Stock Is Soaring Thursday — What's Going On?

ASP Isotopes Stock Is Soaring Thursday — What's Going On?

asp同位素股票週四飆升 — 發生了什麼事?
Benzinga ·  10/18 00:39

ASP Isotopes Inc (NASDAQ:ASPI) shares are moving higher Thursday after the company announced the accelerated commissioning of its first quantum enrichment plant following the successful enriching of Ytterbium-176.

ASP Isotopes公司(納斯達克:asp isotopes)股票週四上漲,此前該公司宣佈首個量子富集工廠的加速投產,成功富集了釔176。

What To Know: ASP Isotopes announced the successful enrichment of Ytterbium-176 using quantum enrichment. The company said it accelerated the commissioning of its first quantum enrichment plant after it produced the first semi-finished material of enriched Ytterbium-176.

值得了解:ASP Isotopes宣佈成功利用量子富集技術富集了釔176。公司表示,在生產了首批富集的釔176半成品後,加速投產了首個量子富集工廠。

ASP Isotopes' Ytterbium-176 enrichment facility was completed in August, approximately nine months ahead of schedule. It's the company's first isotope enrichment plant to utilize laser-based quantum enrichment. The commissioning phase was originally expected to take three to six months, but ASP said it produced enriched Ytterbium-176 during the first six weeks.

ASP Isotopes的釔176富集設施於8月完成,比計劃提前約9個月。這是公司首個利用基於激光的量子富集技術的同位素富集工廠。最初預計投產階段需要三到六個月,但ASP表示在前六週內即生產了富集的釔176。

Based on the results, ASP believes that its plant will be capable of producing approximately 1 kg of highly enriched Ytterbium-176 per year. The company expects to be able to offer Ytterbium-176, enriched to 99.75%, for commercial sale in 2025. Samples are expected to become available in the first quarter.

根據結果,ASP相信其工廠將能夠每年生產約1千克高度富集的釔176。該公司預計2025年能夠提供富集至99.75%的釔176進行商業銷售。樣品預計將於第一季度提供。

"Currently, there exist significant supply-side challenges for many essential radioisotopes used in various oncology treatments. We have received a considerable amount of interest from customers in North America, Europe and Asia for Ytterbium-176 and we look forward to easing supply chains and improving the quality of life for thousands of patients every year", said Paul Mann, executive chairman and CEO of ASP Isotopes.

"目前,許多用於各種腫瘤治療的必需放射性同位素存在重大供應挑戰。ASP Isotopes的執行主席兼首席執行官保羅·曼表示:"我們收到來自北美、歐洲和亞洲客戶對釔176的濃縮感興趣,並期待每年爲成千上萬患者減輕供應鏈壓力,改善生活質量。

Based on the results of the commissioning phase, ASP Isotopes said it's accelerating plans to construct Nickel-64 and Lithium-6/7 plants in South Africa.

根據投產階段結果,ASP Isotopes表示正在加速計劃,在南非建設鎳64和鋰6/7工廠。

The company also noted that it believes its quantum enrichment process will be able to produce HALEU (High Assay Low Enriched Uranium) at an attractive price, allowing new nuclear energy to become available at a "green discount" to carbon-intensive electricity production processes. ASP said it's in discussions with potential customers that anticipate requiring more than $37 billion of HALEU at recent market prices.

該公司還指出,它相信其量子富集過程將能夠以優惠價格生產HALEU(高分析低富集鈾),從而使新的核能以"綠色折扣"的方式在供應鏈中可用,以低碳電力生產過程大幅提升。ASP表示正在與那些預計需要超過370億美元HALEU的潛在客戶進行討論,按照最近市場價格。

"This 'green energy cost advantage' is expected to help accelerate the global adoption of new nuclear energy, with a corresponding benefit to climate goals," the company said.

公司表示:「這種『綠色能源成本優勢』有望加速全球新核能的採用,並對氣候目標產生相應的益處。」

ASP Isotopes is an advanced materials company focused on the development of technology and processes for the production of isotopes. The company aims to become a leading supplier of isotopes that are essential for developments in medicine, quantum computing and green energy production.

asp isotopes是一家專注於科技和流程開發以生產同位素的先進材料公司。該公司旨在成爲醫學、量子計算和綠色能源生產發展中不可或缺的同位素主要供應商。

ASPI Price Action: ASP Isotopes shares were up 21.9% at $4.26 at the time of publication, according to Benzinga Pro.

ASPI股價走勢:ASP同位素股價在發佈時上漲了21.9%,報4.26美元,據Benzinga Pro報道。

Photo: Pixabay.

圖片來源:Pixabay。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論